Cargando…
Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis
BACKGROUND: The impact of bevacizumab (an anti-vascular endothelial growth factor therapy) remains uncertain, which has been the focus of studies on the management of ovarian cancer (OC). We performed a protocol for systematic review and meta-analysis to assess the efficacy and safety of bevacizumab...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702237/ https://www.ncbi.nlm.nih.gov/pubmed/34941162 http://dx.doi.org/10.1097/MD.0000000000028376 |